{"title":"Study on the effect of Aqueous Extract of Bitter Leaf (Vernonia amygdalina) Against Acetaminophen-Induced Liver Damage in Rats","authors":"I. Uchendu","doi":"10.9734/bpi/tipr/v10/11083d","DOIUrl":null,"url":null,"abstract":"Objective: To study the hepatoprotective effect of aqueous extract of Vernonia amygdalina on acetaminophen-induced liver damage in abino wistar rats. \nMethods: Twenty five (25) albino rats weighing (120±20 g) were randomly divided into five (5) groups with five (5) rats per group. Group A served as normal control and received no treatment. Group B received only a single dose of acetaminophen (750 mg/kg, i.p) and served as negative control . Group C served as positive control and received Vitamin C (200 mg/kg, oral) for 2 weeks, while Group D and E served as the test groups and received aqueous bitter leaf extract; high dose (500mg/kg,oral) and low dose (250mg/kg, oral) separately for 2 weeks following acetaminophen challenge. \nResults: The administration of single dose of acetaminophen (750 mg/kg, i.p) resulted in liver damage with AST, ALT and ALP levels: 48.33±10.14U/L, 60.00±13.23U/L and 229.67±23.38U/L respectively. The treatment with bitter leaf resulted in a reversal of the acetaminophen-induced liver damage with AST, ALT and ALP levels: 20.67±1.76U/L (P<0.05), 16.67±3.52U/L (P<0.01) and 131.67±7.27U/L (P<0.01) respectively when compared with acetaminophen alone. Histopathological results also showed minor or non significant hepatocellular damage in the test groups; hence hepatoprotection by Vernonia amygdalina. \nConclusion: The aqueous extract of Vernonia amygdalina possesses hepatoprotective properties against acetaminophen-induced liver damage.","PeriodicalId":22326,"journal":{"name":"Technological Innovation in Pharmaceutical Research Vol. 10","volume":"133 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technological Innovation in Pharmaceutical Research Vol. 10","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/bpi/tipr/v10/11083d","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To study the hepatoprotective effect of aqueous extract of Vernonia amygdalina on acetaminophen-induced liver damage in abino wistar rats.
Methods: Twenty five (25) albino rats weighing (120±20 g) were randomly divided into five (5) groups with five (5) rats per group. Group A served as normal control and received no treatment. Group B received only a single dose of acetaminophen (750 mg/kg, i.p) and served as negative control . Group C served as positive control and received Vitamin C (200 mg/kg, oral) for 2 weeks, while Group D and E served as the test groups and received aqueous bitter leaf extract; high dose (500mg/kg,oral) and low dose (250mg/kg, oral) separately for 2 weeks following acetaminophen challenge.
Results: The administration of single dose of acetaminophen (750 mg/kg, i.p) resulted in liver damage with AST, ALT and ALP levels: 48.33±10.14U/L, 60.00±13.23U/L and 229.67±23.38U/L respectively. The treatment with bitter leaf resulted in a reversal of the acetaminophen-induced liver damage with AST, ALT and ALP levels: 20.67±1.76U/L (P<0.05), 16.67±3.52U/L (P<0.01) and 131.67±7.27U/L (P<0.01) respectively when compared with acetaminophen alone. Histopathological results also showed minor or non significant hepatocellular damage in the test groups; hence hepatoprotection by Vernonia amygdalina.
Conclusion: The aqueous extract of Vernonia amygdalina possesses hepatoprotective properties against acetaminophen-induced liver damage.